Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. The prevalence
of extreme obesity, defined as body mass index (BMI) of 50 kg/m2 or higher, is rising more …

Most patients with nonalcoholic fatty liver disease (NAFLD) are overweight or obese.
However, a significant proportion of patients have a normal body mass index (BMI), denoted …

Although nonalcoholic fatty liver disease (NAFLD) is closely linked to obesity, around 10%‐
20% of nonobese Americans and Asians still develop NAFLD. Data on this special group …

Background The relationship between body mass index (BMI) and outcomes in patients with
nonalcoholic fatty liver disease (NAFLD) is not well defined. This study aimed to assess the …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is associated with
metabolic syndrome. Worryingly, it has been increasingly reported among nonobese …

Backgrounds Non-obese nonalcoholic fatty liver disease (NAFLD) is paradoxically
associated with improved metabolic and pathological features at diagnosis but worse …

In patients with nonalcoholic fatty liver disease (NAFLD), prognosis and outcome, especially
non‐liver‐related mortality, remain incompletely elucidated. We clarified the mortality from …

It remains unclear whether screening for advanced fibrosis in the community can identify the
subgroup of people with nonalcoholic fatty liver disease (NAFLD) at higher risk for …

Methods A total of 246 histologically-proven NAFLD patients were enrolled across 14
centers. We compared the severity of fibrosis in patients with different components of …

Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease
worldwide [1]. It can progress to non-alcoholic steatohepatitis (NASH), cirrhosis and …